Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • MESC, IICS Partner with Shankar Mahadevan Academy to Strengthen India’s Music Education & Creative Talent Ecosystem Business
  • All India Business Community and Foundation (AIBCF) Convenes National Conference on Viksit Bharat in New Delhi Business
  • Samunnati Announces Leadership Transition to Drive “Samunnati 2.0”: The Next Wave of Tech-Led Agri Growth Business
  • Why ‘Largest’ Isn’t the Same as ‘Trusted’: How COWBERRY Is Testing Its Way to Both Business
  • ORCHA and Alpha MD Forge Strategic Partnership to Revolutionise Digital Health Delivery in India Business
  • Futuristic CCTV Technology by Infinova, revolutionizing the Surveillance process in 2023 and the years ahead! Technology
  • Business Mint hosts its 42nd Award Show in Hyderabad – Nationwide Awards 2023 Business
  • Hafele India Showcases Innovation at IndiaWood 2024 Exhibition Business

Speciality Medicines Limited IPO Opens on March 20, 2026

Posted on March 18, 2026 By
Mumbai (Maharashtra) [India], March 18: Speciality Medicines Limited, a company engaged in the marketing and distribution of specialty pharmaceutical products across multiple therapeutic areas, proposes to open its Initial Public Offering on Friday, March 20, 2026 aiming to raise ₹ 29.14 Crore (At Upper Price Band), with shares to be listed on the BSE SME platform.

The issue size is 23,50,000 equity shares at a face value of ₹ 10 each with a price band of
₹ 117- ₹ 124 Per Share.

Equity Share Allocation

  • Qualified Institutional Buyer – Up To 21,000 Equity Shares
  • Non-Institutional Investors – Up To 10,89,000 Equity Shares
  • Retail Individual Investors – Up To 10,90,000 Equity Shares
  • Market Maker – Up To 1,50,000 Equity Shares

The net proceeds from the IPO will be utilized for Setting up of Research and Development (R&D) Centre, Product Registration in International Markets and Product Development for sale in international markets, Funding for Marketing and Promotional Activities, To Meet Working Capital Requirements and General Corporate Purposes. The issue will open on Friday, Mar 20, 2026 and will close on Tuesday, Mar 24, 2026.

The Book Running Lead Manager to the Issue is Unistone Capital Private Limited, The Registrar to the Issue is Skyline Financial Services Private Limited.

Mr. Parth Goyani, Chairman & Managing Director of Speciality Medicines Limited expressed, “We have built Speciality Medicines Limited with a strong focus on providing access to high-value specialty pharmaceutical products across critical therapeutic areas such as oncology, immunology and neurology. Over the years, our distribution strength, customer relationships and product portfolio have helped us expand our presence across more than 20 states in India and several international markets.

The proposed IPO marks an important milestone in our growth journey. The proceeds will primarily be utilized to establish a dedicated Research & Development center, strengthen product registrations in international markets, expand our marketing and promotional reach, and support working capital requirements. These initiatives will enable us to broaden our product portfolio, deepen our global footprint and enhance our ability to deliver innovative solutions for complex chronic conditions.

We believe this capital infusion will significantly strengthen our capabilities and position the company for sustainable long-term growth.”

Mr. Brijesh Parekh, Founder & Director of Unistone Capital Private Limited said, “We are delighted to be associated with the proposed IPO of Speciality Medicines Limited and to support the company in this important milestone of its growth journey. The company has built a strong presence in the specialty pharmaceuticals segment with a diversified portfolio products and a growing footprint across India and international markets.

The company’s focus on high-value therapeutic areas and its strong distribution network position it well to capture opportunities in the rapidly expanding specialty pharmaceutical market.

The proceeds from the IPO will support the establishment of a dedicated R&D center, expansion of product registrations in international markets, strengthening of marketing initiatives, and funding of working capital requirements. We believe these initiatives will further enhance the company’s growth prospects and help it scale its operations in both domestic and global markets.”

Disclaimer: This article is for informational purposes only and does not constitute financial advice.

Business Tags:Business

Post navigation

Previous Post: Ahmed Al Maghribi Unveils Exclusive Eid Gifting
Next Post: IPS Academy Strengthens Community Bonding Through Holi Milan Samaroh

Related Posts

  • Spark PWM Expands Presence in South India with New Hyderabad Office Business
  • Genesis Pain Clinics Brings Cutting-Edge Pain Management and Regenerative Therapy to Hyderabad Business
  • Vikas Ecotech Board Paybacks 2 trenches of Debt under its Debt Reduction Program Phase-II, Aiming to Enter Zero Debt Regime Business
  • From Indian Enterprise to Global Ambition: Dr. Sachidanand Upadhyay Marks Third Consecutive Year in TIME Magazine Business
  • Arkade Developers Consolidated Q4 FY25 Net Profit Grew By 70% Business
  • Varmora Group is set to invest Rs. 250 Crore in State-of-the-Art Tiles Production Plant with the latest Technology in Morbi Business

Recent Posts

  • PPFAS Asset Management appoints Devendra Ghalsashi as Chief Operating Officer
  • Irfan Pathan and Adah Sharma Grace the Launch of Youth Cricket League’s YCLT10
  • From Military Service to Social Change: Ramesh Sangle Explores Nation-Building in BRIGADE
  • Samiran Tea Unveils New Product Portfolio, Including 10 Herbal Tea Blends, at Noida Office Inauguration
  • Manav’s ‘Bardic Voices: Where the Horizon Meets, the Magic Begins’ Explores Memory, Humanity, and the Search for Meaning

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Award-winning architecture firm APICES Studio announces strategic expansion into Gujarat Business
  • Lakhyadhik Jansampark reaches out to 1 lakh people simultaneously National
  • Mittali Kaur To Represent India at International Level After Being Crowned Miss Intercontinental India 2021 Lifestyle
  • Minerva Ventures Fund bought total 2 Percent stake in KBC Global Ltd Business
  • Find Your Mojo: Transformative Residency Retreats by The Bonding Boulevard Business
  • Sarthak Metals Limited announced its Q4 & FY22 Results Business
  • Hidden Treasures on Netflix: The Brilliant, the Flawed and the Forgotten Entertainment
  • Expert Neurosurgeon Dr. Gurneet Singh Sawhney performs awake brain surgery to give a new lease of life to a 34-year-old woman with a brain tumor Health

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme